EMA letter of support for INNODIA
22. October 2021
The European Medicins Agency supports the adaptation of the INNODIA Master Protocol in Type 1 Diabetes for studies in prevention. The protocol aims to track progression from the appearance of auto-antibodies (AA+), to dysglycemia, to the full presentation with symptomatic disease.